We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+12.09%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$683M
AUM Growth
-$101M
Cap. Flow
-$82.5M
Cap. Flow %
-12.08%
Top 10 Hldgs %
52.33%
Holding
153
New
26
Increased
35
Reduced
53
Closed
35

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$20M
2
BIIB icon
Biogen
BIIB
+$11.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.32M
4
ORA icon
Ormat Technologies
ORA
+$5.09M
5
OPK icon
Opko Health
OPK
+$5.01M

Top Sells

Rank Stock Value
1
ESLT icon
Elbit Systems
ESLT
+$29.2M
2
SHPG
Shire pic
SHPG
+$27M
3
AGN
Allergan plc
AGN
+$23M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$12.7M
5
VTRS icon
Viatris
VTRS
+$9.62M

Sector Composition

Rank Sector Weight
1 Healthcare 60.65%
2 Utilities 5.79%
3 Technology 1.86%
4 Consumer Discretionary 1.38%
5 Communication Services 1.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBBP
101
DELISTED
Strongbridge Biopharma plc.
SBBP
$1.38M 0.2%
+181,818
New +$1.31M
KALV
102
DELISTED
KalVista Pharmaceuticals
KALV
$1.3M 0.19%
25,714
-2,857
-10% -$150K
PRQR icon
103
ProQR Therapeutics
PRQR
$243M
$1.3M 0.19%
+150,000
New +$1.73M
LOXO
104
DELISTED
Loxo Oncology, Inc
LOXO
$1.28M 0.19%
+45,000
New +$1.21M
MNKD icon
105
CALL
MannKind Corp
MNKD
$1.21B
$1.1M 0.16%
+152,000
New +$1.87M
WAB icon
106
Wabtec
WAB
$49.1B
$908K 0.13%
12,761
-9,974
-44% -$797K
ARRY
107
DELISTED
Array Biopharma Inc
ARRY
$907K 0.13%
215,000
-135,000
-39% -$616K
APTV icon
108
Aptiv
APTV
$12B
$863K 0.13%
10,065
+915
+10% +$76.5K
ELLO icon
109
Ellomay Capital Ltd
ELLO
$270M
$824K 0.12%
95,653
-125,444
-57% -$1.08M
WIX icon
110
WIX.com
WIX
$2.3B
$807K 0.12%
35,460
-22,700
-39% -$511K
CHTR icon
111
Charter Communications
CHTR
$17.3B
$737K 0.11%
4,026
– –
ATXS
112
DELISTED
Astria Therapeutics
ATXS
$640K 0.09%
1,346
-4,112
-75% -$1.97M
EZCH
113
DELISTED
EZCHIP SEMICONDUCTOR LIMITED ORD SHS (IL)
EZCH
$505K 0.07%
+20,447
New +$503K
BMRN icon
114
BioMarin Pharmaceuticals
BMRN
$11.6B
$388K 0.06%
3,700
-121,300
-97% -$12.7M
ATYR
115
aTyr Pharma
ATYR
$47.6M
$358K 0.05%
2,604
-12,327
-83% -$1.75M
GNVC
116
DELISTED
GenVec, Inc.
GNVC
$343K 0.05%
18,650
-17,383
-48% -$332K
ICL icon
117
ICL Group
ICL
$6.53B
$280K 0.04%
+69,083
New +$347K
AOS icon
118
A.O. Smith
AOS
$8.17B
$207K 0.03%
5,400
-15,482
-74% -$584K
AMGN icon
119
Amgen
AMGN
$208B
– –
-50,200
Closed -$6.94M
ASRT
120
DELISTED
Assertio
ASRT
– –
-6,000
Closed -$6.79M
CYTK icon
121
Cytokinetics
CYTK
$10.5B
– –
-372,250
Closed -$2.49M
ESLT icon
122
Elbit Systems
ESLT
$37.9B
– –
-100,618
Closed -$29.2M
FOLD
123
DELISTED
Amicus Therapeutics
FOLD
– –
-310,000
Closed -$4.34M
INSM icon
124
Insmed
INSM
$21.4B
– –
-165,000
Closed -$3.06M
LRMR icon
125
Larimar Therapeutics
LRMR
$397M
– –
-3,333
Closed -$1.28M
3 4
5
6 7

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q4 2015 Portfolio in Review

As of Q4 2015, Sphera Funds Management held 153 positions worth $683M, down 13% from $784M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sphera Funds Management withdrew a net $82.5M in Q4 2015, closing 35 positions and reducing 53 holdings. Its most notable exit was Elbit Systems, an estimated $29.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 56% a quarter earlier, followed by Utilities and Technology.

Against the trend, Sphera Funds Management opened a new position in Alphabet (Google) Class C worth $5.76M.

  • Sphera Funds Management's largest Q4 2015 buy was Alphabet (Google) Class C: 148,180 shares worth $5.76M.
  • Sphera Funds Management added most to Pfizer in Q4 2015, an estimated $20M increase.
  • Sphera Funds Management's biggest Q4 2015 reduction was Shire pic, cutting an estimated $27M.
  • Sphera Funds Management fully exited Elbit Systems in Q4 2015, selling an estimated $29.2M.
  • Sphera Funds Management's ten largest holdings make up 52% of its $683M portfolio in Q4 2015.
  • Sphera Funds Management opened 26 new positions and closed 35 in Q4 2015.
  • Sphera Funds Management's portfolio value fell 13% quarter-over-quarter to $683M.

Based on Sphera Funds Management's 13F filing for Q4 2015, filed 11 Feb 2016.